Under-Treatment of Patients with Moderate to Severe Psoriasis in the United States: Analysis of Medication Usage with Health Plan Data

door Armstrong, April W., Koning, J. Will, Rowse, Simon, Tan, Huaming, Mamolo, Carla, Kaur, Mandeep
Gepubliceerd in Dermatol Ther (Heidelb) (2016)

A multi-item Physician Global Assessment scale to assess psoriasis disease severity: validation based on four phase III tofacitinib studies

door Callis Duffin, Kristina, Bushmakin, Andrew G., Cappelleri, Joseph C., Mallbris, Lotus, Mamolo, Carla
Gepubliceerd in BMC Dermatol (2019)

Randomized trial of tofacitinib in active ulcerative colitis: analysis of efficacy based on patient-reported outcomes

door Panés, Julián, Su, Chinyu, Bushmakin, Andrew G, Cappelleri, Joseph C, Mamolo, Carla, Healey, Paul
Gepubliceerd in BMC Gastroenterol (2015)

Social preferences for health states associated with acute myeloid leukemia for patients undergoing treatment in the United Kingdom

door Castejón, Nacho, Cappelleri, Joseph C., Cuervo, Jesús, Lang, Kathryn, Mehta, Priyanka, Mokgokong, Ruth, Mamolo, Carla
Gepubliceerd in Health Qual Life Outcomes (2018)

Humanistic and Economic Burden of Non-Muscle Invasive Bladder Cancer: Results of Two Systematic Literature Reviews

door Lee, Lauren J, Kwon, Christina S, Forsythe, Anna, Mamolo, Carla M, Masters, Elizabeth T, Jacobs, Ira A
Gepubliceerd in Clinicoecon Outcomes Res (2020)

Budget Impact Analysis of Gemtuzumab Ozogamicin for the Treatment of CD33-Positive Acute Myeloid Leukemia

door Mamolo, Carla, Welch, Verna, Walter, Roland B., Cappelleri, Joseph C., Brockbank, James, Cawson, Matthew, Knight, Chris, Wilson, Michele
Gepubliceerd in Pharmacoeconomics (2020)

Relationship between molecular response and quality of life with bosutinib or imatinib for chronic myeloid leukemia

door Brümmendorf, Tim H., Gambacorti-Passerini, Carlo, Bushmakin, Andrew G., Cappelleri, Joseph C., Viqueira, Andrea, Reisman, Arlene, Isfort, Susanne, Mamolo, Carla
Gepubliceerd in Ann Hematol (2020)

Treatment of plaque psoriasis with an ointment formulation of the Janus kinase inhibitor, tofacitinib: a Phase 2b randomized clinical trial

door Papp, Kim A., Bissonnette, Robert, Gooderham, Melinda, Feldman, Steven R., Iversen, Lars, Soung, Jennifer, Draelos, Zoe, Mamolo, Carla, Purohit, Vivek, Wang, Cunshan, Ports, William C.
Gepubliceerd in BMC Dermatol (2016)

Long‐term patient‐reported outcomes from an open‐label safety and efficacy study of bosutinib in Philadelphia chromosome–positive chronic myeloid leukemia patients resistant or int...

door Kantarjian, Hagop M., Mamolo, Carla M., Gambacorti‐Passerini, Carlo, Cortes, Jorge E., Brümmendorf, Tim H., Su, Yun, Reisman, Arlene L., Shapiro, Mark, Lipton, Jeff H.
Gepubliceerd in Cancer (2017)

Effect of Biologic Agents on Non-PASI Outcomes in Moderate-to-Severe Plaque Psoriasis: Systematic Review and Meta-Analyses

door Baker, Erica L., Coleman, Craig I., Reinhart, Kurt M., Phung, Olivia J., Kugelman, Lisa, Chen, Wendy, White, C. Michael, Mamolo, Carla M., Cappelleri, Joseph C., Baker, William L.
Gepubliceerd in 2012